Revised MRPs of 1,364 Anti-Cancer Medicine Formulations Effective from 9 November 2026; Consumers Expected to Save ₹3,540 Crore Annually

Ø Consumers to Save ₹3,540.38 Crore Annually

· Revised Prices Implemented: New Maximum Retail Prices (MRPs) of 1,364 anti-cancer medicine formulations have come into effect from 9 November 2026.

· NPPA Price Regulation: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has capped trade margins on 137 anti-cancer drugs based on recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS) on 17 October 2026.

· Companies Covered: As of 8 November 2026, 85 pharmaceutical companies have reported revised MRPs covering 121 drugs and 1,364 formulations.

· Substantial Price Reduction: Out of the reported brands, 679 have registered MRP reductions of more than 50%.

· Maximum Price Reduction: The highest reported reduction in the MRP of an anti-cancer medicine is 96.45%.

· Annual Consumer Savings: The revised pricing structure is expected to generate estimated annual savings of ₹3,540.38 crore for consumers.

· Price Verification: Consumers can check revised medicine prices through the Pharma Sahi Daam mobile application and the official NPPA website: https://nppa.gov.in/.

· Protection Against Overcharging: Chemists and hospital pharmacies cannot charge consumers more than the revised MRP printed on medicine packs.

· Grievance Redressal: Consumers can report overcharging and other pricing-related complaints through the Pharma Jan Samadhan portal or NPPA helpline at 1800-111-255.

[ABS News Service/09.11.2026]

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs, based on the recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS), Ministry of Health & Family Welfare, on 17th October, 2026. The revised MRPs of these medicines come into effect from today, 9th November, 2026.

As on 8th of November, 2026, 85 Pharmaceutical Companies have reported revised MRPs for 1,364 anti-cancer formulations, covering 121 drugs. With 679 brands reporting price reductions of more than 50%. The highest reported reduction in MRP is 96.45%. As a result of the price reductions the estimated annual savings to consumers is expected to be ₹3,540.38 crore.

Consumers can check the revised MRP printed on the medicine pack and verify medicine prices through the Pharma Sahi Daam mobile app or NPPA website (nppa.gov.in). No chemist or hospital pharmacy can charge more than the revised MRP. In case of overcharging or any other pricing-related complaint, consumers can register their grievance through the Pharma Jan Samadhan portal or contact the NPPA helpline at 1800-111-255.